Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pAAV-RHO-IntC-dCas9C-VPR-polyA Citations (1)

Originally described in: A gene therapy for inherited blindness using dCas9-VPR-mediated transcriptional activation.
Bohm S, Splith V, Riedmayr LM, Rotzer RD, Gasparoni G, Nordstrom KJV, Wagner JE, Hinrichsmeyer KS, Walter J, Wahl-Schott C, Fenske S, Biel M, Michalakis S, Becirovic E Sci Adv. 2020 Aug 19;6(34):eaba5614. doi: 10.1126/sciadv.aba5614. eCollection 2020 Aug. PubMed Journal

Articles Citing pAAV-RHO-IntC-dCas9C-VPR-polyA

Articles
dCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy. Riedmayr LM, Hinrichsmeyer KS, Karguth N, Bohm S, Splith V, Michalakis S, Becirovic E. Nat Protoc. 2022 Mar;17(3):781-818. doi: 10.1038/s41596-021-00666-3. Epub 2022 Feb 7. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.